Conference Pricing | Speakers | Register | Sponsor OpportunitiesConference Full ScheduleRegister for the conference by March 5th before the Early Bird rates expire!
|
5:00-9:00 p.m. |
Pre-Conference Session |
5:00-6:00 p.m. - Basic Life Support (BLS) - Recertification
6:00-7:30 p.m.- Advanced Cardiac Life Support (ACLS) - Recertification
7:30-9:00 p.m. - Pediatric Advanced Life Support (PALS) - Recertification
Thank you to our Saturday Headline Sponsor:
|
|
7:45 - 8:00 a.m. |
Opening Statements - OANA President, Leah Coyle, CRNA |
8:00 - 9:00 a.m. |
General Session |
This content will examine the development of pain policy and clinical prac tice as it relates to political decision making and public policy. In addition, the influence of pharmacological entities in the develoment of these policies and practices
Learning Objective:
Examine and explore public policy, clinical practice and the resultant pain policies adopted by facilities.
9:00 - 10:00 a.m. |
General Session |
This content will explore Ketamine infusions in the current clinical practice environment as well as the use of Ketamine for chronic refractory depression, PTSD and CRPS.
Learning Objective:
Examine and discuss the use of Ketamine for CRPS, TRD/CRD, PTSD as well as the pharmacodynamics and pharmacokinetics of Ketamine
10:00 - 10:30 a.m. |
Break |
10:30 a.m. - 11:30 a.m. |
General Session |
Nearly 130 million Americans suffer from various forms of chronic pain. When these patients present for procedures or surgery requiring anesthesia, routine
opioid-based anesthetic techniques are not sufficient. There is a requirement for a multi-modal alternate approach that is required to achieve pain relief.
Learning Objectives:
11:30 a.m. -12:30 p.m. |
General Session |
Leadership is about creating a vision for the future, designing social architecture that shapes culture and values, inspiring and motivating followers, developing personal qualities, and creating change within a culture of integrity. Leadership can be integrated with management to achieve the greatest possible outcomes. The goal is for the attendees to gain a self-awareness of importance in the vulnerability in leadership that is required for success.
Learning Objectives:
12:30 - 1:30 p.m. |
Lunch Break |
General Session |
This content will explore the use of Botox for cosmetic and none cosmetic uses. The development of Botox, the use of Botox in the clinical setting as well as the pharmocodynamics and pharmacokinetics of Botox.
Learning Objective:
Examine, discuss and illustrate the use of Botox for cosmetic and non cosmetic clinical uses
ERAS is quickly becoming the new norm in patient outcomes. CRNAs play a pivotal role on transforming healthcare delivery across the phases of ERAS. Historically, CRNAs have under appreciated the value they bring outside of the perioperative period and intangible contributions throughout the perioperative phases of care.
The learner will be able to:
3:45-4:45 p.m. |
General Session |
This session will be a review current AANA issues associated with member engagement, advocacy, reimbursement, educational and learning initiatives. There will also be a discussion regarding trends in anesthesia practice based on the most recent, available AANA data as well as how the current healthcare transformation can impact anesthesia practice in Oklahoma.
1) Identify trends in anesthesia practice based on the most recent, available AANA data.
2) Discuss key AANA issues associated with member engagement, advocacy, reimbursement, educational and learning initiatives.
3) Determine how current healthcare transformation impact anesthesia practice trends in
Oklahoma
7:30 a.m. |
Meeting open for Login |
8:00 - 9:00 a.m. |
General Session |
This session will be a discussion of neuro anatomy and physiology as well as a review of common neuromuscular disorders and their specific pathophysiology and specific anesthetic management for these disorders.
1. Recognize and understand neuromuscular anatomy and physiology
2. Understand pathophysiology associated with common neuromuscular disorders
3. Recognize signs and symptoms of various neuromuscular disorders
4. Discuss anesthetic management for specific neuromuscular disorders
9:00 - 10:00 a.m. |
General Session |
Opioids are killing people and CRNAs have a role in mitigating the opioid crisis. CRNAs possess an opportunity to be the drivers of health care policy within the opioid crisis. The opportunity to define a CRNA’s contributions economically and legislatively remain as uncharted territory. This lecture serves to describe the economic forces a CRNA can wield through practices changes in the future.
The learner will be able to:
10:30 - 11:30 a.m. |
General Session |
As the population ages, longevity imparts technologies (i.e. pacemakers and defibrillators) that challenge the everyday anesthetic. An intimate understanding of these technologies and how our care influences the device behaviors under anesthesia is crucial. A brief overview of the basics and the critical anesthesia considerations during preoperative evaluation are essential to ensuring the patient’s safety under a CRNA’s care.
The learner will be able to describe:
|
|
11:30 a.m. - 12:30 p.m. |
General Session |
New anticoagulants are being developed daily with greater efficacy with safer patient profiles. As anesthesia providers, it is imperative to understand the nuances in the pharmacokinetics in providing safe regional anesthesia.
Learning Objectives:
One of the most underappreciated skills is leadership competency assessment. A basic description on leadership and leadership development is imperative for any individual to understand. A self-reflection on strengths and weaknesses is imperative to define one’s passion for leadership opportunity. Once you understand yourself, the opportunity to pursue leadership opportunities becomes more clear.
The Learner will be able to:
Register for the conference by March 5th before the Early Bird rates expire!